PTGX Similar Chart Price Prediction
The price of PTGX is predicted to go up -7.76%, based on the high correlation periods with WDH. The similarity of these two price pattern on the periods is 93.36%.
PTGX
WDH
Down: -7.76%Similarity: 93.36%
PTGX Revenue Forecast
PTGX EPS Forecast
PTGX FAQs
What is bull’s view on PTGX?
What is bear's view on PTGX?
What is PTGX revenue forecast for next quarter？
PTGX Analyst's Forecast
Tara Bancroft
TD Cowen
Strong Buy
2024-09-24
Price Target
$65
Upside
+39.54%
TD Cowen analyst Tara Bancroft initiated coverage of Protagonist Therapeutics with a Buy rating and $65 price target. The firm says the company's rusfertide has at least $3B of sales potential in polycythemia vera, with $1B going to Protagonist, and JNJ-2113 can address the 5M plaque psoriasis and ulcerative colitis patients seeking an oral option. Protagonist's pipeline should also generate future value for years to come, the analyst tells investors in a research note.
